Skip to content
Search

Latest Stories

'Closure of Lloyds Pharmacy branches will wake-up ministers to reality of funding crisis faced by community pharmacy'

Lloyds Pharmacy’s closure of all its 1,300 branches will wake-up the ministers and NHS officials to the reality of community pharmacy sector in England has reached crisis point, expressed Nigel Swift Managing Director of Rowlands pharmacy and Deputy Managing Director of PHOENIX UK.

On Friday, The SUN reported that the UK’s second largest pharmacy provider - is allegedly in the process of selling its entire estate of 1300 branches. Lloyds Pharmacy will no longer be a High Street presence following its decision to put all its pharmacy branches at the risk of closure. In January it has announced to close its 237 Sainsbury-based pharmacies.


However, a spokesperson for LloydsPharmacy has confirmed with Pharmacy Business that except its stores in Sainsbury's, no other LloydsPharmacy store is at risk of closure.

“LloydsPharmacy is reviewing its community pharmacy estate and is selectively selling some branches. No LloydsPharmacy store is at risk of closure, except those within the Sainsbury’s estate."

“The majority of buyers of these selected branches are independent pharmacy owners and local businesspeople who have demonstrated that they are committed to our branch teams and patients, and are well placed to meet the ongoing health needs of the local community.

“The LloydsPharmacy team is pleased that its colleagues from these stores will be joining successful, local businesses and that for patients there will be no change in the way they use their local pharmacy.”

Nigel highlighted the fact that community pharmacy is struggling due to insufficient government funding and immense pressures on GPs and A&E departments – an ongoing issue which poses a very real threat to the sector.

Commenting on the announcement, he said: “It’s not just Lloyds – an independent analysis by Ernst & Young estimated that 75% of community pharmacies will be in financial distress in the coming years. £750 million has been taken out of the English contract due to inflation since it began."

“We have seen hundreds of random closures in recent years – and more will follow - which has resulted in people having less access to essential NHS care, support and advice. That lack of access then piles additional pressures on GPs and A&E departments which are already struggling to cope with patient demand. This makes no sense.”

“The governments in Scotland and Wales are investing in community pharmacy because they understand how that benefits patients and the NHS overall. Yet in England, Ministers are saying they want pharmacy to do more with no new funding at a time when prescription volumes are growing. This is economically illiterate hence the understandable decision by Lloyds pharmacy – which made a £66m loss last year despite Covid-related support - to exit the UK High Street.”

“The English Health Minister talks about implementing a “pharmacy first” approach to relieve pressures on GPs and A&E departments. That cannot be delivered through a network which clearly is under-funded and in decline. Not all 1300 Lloyds pharmacies will close: some will be bought but the trend is clear: fewer pharmacies, less patient access and more pressure on other parts of the NHS. Now more than ever before we need government in England to engage with us, recognise there is a patient care crisis and agree a way forward.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less